Abbott Laboratories agrees to pay about $385 million to resolve U.S. government and civil claims linked to problems at a Michigan baby formula plant, including a 2022 recall of powdered infant formula. The settlement amount is reported as $385 million or $384,999,040, depending on the source.
According to the U.S. Department of Justice, the resolution covers allegations that false claims were submitted to federal and state programs. The DOJ statement says the conduct at issue is tied to a period from January 1, 2018, through December 31, 2022, and relates to manufacturing issues identified during the investigation.
Other outlets describe the settlement as connected to claims raised after the company’s manufacturing and the 2022 recall, which followed concerns about contamination at the facility. The reports generally align on the amount and the Michigan plant link, while differing mainly in how they emphasize the DOJ’s legal framing versus broader references to the plant’s closure and the recall.
